Why Invest in Ludwig Enterprises
- The WHO estimates that 50% of the world’s deaths are a result of illnesses such as cancer, diabetes, COPD & heart disease that has chronic inflammation as a causation.
- The mRNA Inflammatory Index™ is a patent pending technology combined with AI that assesses the biomarkers of chronic inflammation.
- NuGenea™ is a scientifically formulated nutraceutical proven through extensive research to reduce chronic inflammation
Why Invest in Ludwig’s mRNA Technology?
- The mRNA market is $39.9 Billion
- It is growing at 1.7% per year
- Ludwig’s holds a unique position in this growing industry!
- The mRNA Inflammatory Index™ is an assay that measures mRNA levels in body
Why Invest in Ludwig’s NuGenea™
- Patent Pending Unique Nutraceutical that combats chronic inflammation
- The Worldwide Nutraceutical Industry is about $261Billion in 2022
- It is growing at 9.4% Annually
- 50% of adults in industrialized countries engage in self-directed healthcare
Investor
The World Health Organization estimates that 50% of deaths worldwide are caused by inflammation related chronic diseases such as Heart Disease, COPD, Diabetes and various cancers. Ludwig Enterprises, Inc.(OTC: LUDG) The Genomics Language Company™ and Dr. Marvin S. Hausman MD have created a one-of-a-kind technology that measures 48 different mRNA biomarkers, proven scientifically to be indicators of chronic inflammation. Combined with AI and deep machine learning the mRNA Inflammatory Index™ (patent pending) can have a significant potential positive impact on the health of the world’s population possible driving the prevention of chronic illnesses and potentially achieving early detection for certain cancers.
Results from initial assessments helped gain IRB approval for a clinical study for early detection of bladder cancer and it’s recurrence and shows promising results for the early detection of colon cancer.
Ludwig Enterprises is launching it’s groundbreaking nutraceutical, NuGenea™, a scientifically created formula (patent pending) in Q2 2023. Its compounds have been proven through extensively research to regulate the biomarkersassociated with chronic inflammation. Ludwig believes that NuGenea™ may be THE nutritional supplement that helps people around the world fight the development oflife threatening chronic illnesses and cancers.
Healthcare Professional Message
“Chronic Inflammatory Disease have been recognized as the most significant cause of death in the world today, with more than 50% of all deaths been attributable to inflammation-related diseases.” (https://www.ncbi.nlm.nih.gov/books/NBK493173/)
Ludwig Enterprises, Inc. The Genomics Language Company™ has developed two new tools to be used the fight against chronic inflammation, the mRNA Inflammatory Index™ and NuGenea™.
The mRNA Inflammatory Index™, created by Dr. Marvin S. Hausman MD, assess 48 mRNA biomarkers such as the pro-inflammatory cytokines like IL-10, IL-1B and TNF-a. Combined with AI and deep machine learning Ludwig is creating a database that may help clinicians identify for their patients whether or not they are facing chronic inflammatory processes that may lead to chronic illness or cancer.
NuGenea™ is a scientifically formulated nutraceutical with over 20 compounds that have been proven through exhaustive research to modulate cytokines and chemokines and potentially reduce inflammation.
For the first, as a healthcare professional, you may be able to continually assess your patient’s inflammatory status over time through the use of the mRNA Inflammatory Index™, create a treatment plan that includes behavioral changes and NuGenea™ that may reduce inflammation and then check results to determine if your plan is working.
Consumer Message – NuGenea™
The World Health Organization estimates that 50% of deaths worldwide are caused by inflammation related chronic diseases such as Heart Disease, COPD, Diabetes and various cancers. There are nutritional supplement formulas available to help in the fight again chronic inflammation. However, their formulas are limited and their ingredients only focus on very small number of the causes of chronic inflammation.
NuGenea™ is unique. It is a scientifically created formula (patent pending) that contains 20 different compounds proven through extensive scientific research to regulate over 32 biomarkers that play a part in the creation and continuation of chronic inflammation. Ludwig Enterprises believes that NuGenea™ may be THE groundbreaking nutritional supplement that helps people around the world reduce chronic inflammation and fight the development of life-threatening illnesses like diabetes, COPD, heart disease and cancer.